Colorectal adenomas in patients presenting with inflammatory bowel disease

被引:0
|
作者
Loffeld, R. J. L. F. [1 ]
机构
[1] Zaans Med Ctr, Dept Internal Med, Zaandam, Netherlands
来源
NETHERLANDS JOURNAL OF MEDICINE | 2009年 / 67卷 / 01期
关键词
Adenoma; cancer risk; colorectal cancer; inflammatory bowel disease; ulcerative colitis; ULCERATIVE-COLITIS; CANCER SURVEILLANCE; RISK; DYSPLASIA; POLYPS; MANAGEMENT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Adenoma is the precursor of colorectal carcinoma (CRC). Patients with longstanding active ulcerative colitis (UC) are at risk of developing CRC. Every patient with UC can also develop adenomas, which is an extra risk factor. Aim: A large retrospective cross-sectional study was conducted to identify patients with UC and polyps. Material and methods: All consecutive lower intestinal endoscopies carried out in a period of 16 years were searched for the presence of inflammation and concomitant polyps. Results: Inflammatory bowel disease was diagnosed in 1029 patients. Forty-seven (4.5%) patients had concomitant polyps. The patients with polyps were divided in two groups: group 1 consisted Of 34 patients in whom active inflammation was seen with coinciding polyp(s), and group 2 consisted of 12 patients in remission, in whom polyps were detected. One patient had had adenomas in the past and presented with active inflammation and a new adenoma. In group 1, four patients had a history of active inflammation, and adenomas were seen in 29 patients, while seven patients showed hyperplastic polyps. Two patients had adenomas as well as hyperplastic polyps. In group 2 nine patients had adenomas and three had hyperplastic polyps. Conclusion: Patients with different phenotypic expressions of inflammatory bowel disease can have concomitant adenomas in the colon. Hence, it is plausible to assume that these patients have an increased risk of developing CRC because of adenomas.
引用
收藏
页码:21 / 24
页数:4
相关论文
共 50 条
  • [1] PREVALENCE, CHARACTERISTICS AND DEMOGRAPHIC ASSOCIATIONS OF COLORECTAL ADENOMAS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Goh, Germain SongLing
    Hartono, Juanda Leo
    Lee, Jonathan
    Koh, Calvin
    Lim, Li-Lin
    Wong, Reuben Kong-Min
    Cheong, Wai-Kit
    Tan, Ker-Kan
    Zhu, Feng
    Yeoh, Khay-Guan
    GUT, 2022, 71 : A168 - A169
  • [2] DYSPLASIA AND EARLY CARCINOMA IN INFLAMMATORY BOWEL-DISEASE AND COLORECTAL ADENOMAS
    PASCAL, RR
    HUMAN PATHOLOGY, 1994, 25 (11) : 1160 - 1171
  • [3] Adenomas in Patients With Inflammatory Bowel Disease: Increased Risk of Advanced Neoplasia
    Mooiweer, Erik
    van Schaik, Fiona D.
    Have, Mike V.
    Belderbos, Tim D.
    ten Kate, Fiebo J.
    Offerhaus, Johan
    Schipper, Marguerite E.
    Dijkstra, Gerard
    Pierik, Marie J.
    Stokkers, Pieter
    Ponsioen, Cyriel
    De Jong, Dirk J.
    Hommes, Daniel W.
    van Bodegraven, Adriaan A.
    Siersema, Peter D.
    van Oijen, Martijn G.
    Oldenburg, Bas
    GASTROENTEROLOGY, 2012, 142 (05) : S638 - S638
  • [4] The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease
    Axelrad, Jordan E.
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (06) : 1181 - 1185
  • [5] Management of colorectal cancer in patients with inflammatory bowel disease
    D. O. Kavanagh
    M. C. Carter
    D. Keegan
    G. Doherty
    M. J. Smith
    J. M. P. Hyland
    H. Mulcahy
    K. Sheahan
    P. R. O’ Connell
    D. P. O’ Donoghue
    D. C. Winter
    Techniques in Coloproctology, 2014, 18 : 23 - 28
  • [6] Colorectal cancer risk in patients with inflammatory bowel disease
    Keller, R
    Fischbach, W
    LEBER MAGEN DARM, 2000, 30 (01) : 14 - 20
  • [7] Do Sporadic Adenomas Behave Differently in Inflammatory Bowel Disease Patients?
    Davis, Jessica
    Rieders, Brandon
    Nassereddine, Samah
    Lattimer, Lakshmi
    Khanijow, Vikesh
    Taneja, Sonia
    Myint, Aung
    Al-Shahrani, Abdullah A.
    Borum, Marie L.
    GASTROENTEROLOGY, 2015, 148 (04) : S245 - S245
  • [8] Management of colorectal cancer in patients with inflammatory bowel disease
    Kavanagh, D. O.
    Carter, M. C.
    Keegan, D.
    Doherty, G.
    Smith, M. J.
    Hyland, J. M. P.
    Mulcahy, H.
    Sheahan, K.
    O' Connell, P. R.
    O' Donoghue, D. P.
    Winter, D. C.
    TECHNIQUES IN COLOPROCTOLOGY, 2014, 18 (01) : 23 - 28
  • [9] Patients at risk for colorectal cancer in inflammatory bowel disease
    Bernstein, C. N.
    STRATEGIES OF CANCER PREVENTION IN GASTROENTEROLOGY, 2009, 165A : 92 - 96
  • [10] Surveillance for colorectal cancer in patients with inflammatory bowel disease
    Hurley, Joanna J.
    Turner, Jeff
    Berrill, James
    Swift, Gillian
    Dolwani, Sunil
    Green, John
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (10) : 562 - 567